A study that histologically analyzed lung tissue from lung cancer patients stated that CD133+ endothelial progenitor cells contributed to neovascularization and tumor growth vascular damage was not reported after using CD133 targeted constructs but data implicate the potential of capillary complications after administration. Here, PROM1 is linked to neoplasm.